Biogenerics (Interferon beta; FSH; Mabs); Recombinant human
Heparanase (HepaOne), anti-cancer NCEs, Heparanase-based
diagnostics, Heparanase-neutralizing Mabs.
Employees: 55
Overview
INSIGHT BIOPHARMACEUTICALS LTD. specializes in the discovery,
Click here to request more information, about this company (FOR COLLABORATION IN R&D. ONLY!)
Note - you have to be registered in this server to
request information. If you haven't done so
yet, please register in this server
Your requests will be forwarded to the developer, who
will contact you directly
You can also see the list of
documents you already requested more information about
development, production and marketing of ethical
biopharmaceuticals and biogenerics.
During the past ten years INSIGHT has created a wide and diverse
portfolio of products and technologies.
Since 1995 INSIGHT has been a pioneer in introducing high added
value biogenerics to important markets and has established strong
alliances for technology transfer and product development. The
Company offers a diverse line of biogeneric products, active
pharmaceutical ingredients and efficient manufacturing
technologies.
As a major part of its portfolio INSIGHT is developing front-edge
biopharmaceuticals, novel drugs and diagnostic tools. The Company
maintains active R&D programs in cancer, inflammation, stem cell
transplantation and additional therapeutic areas. INSIGHT has a
rich pipeline of small molecule new chemical entities and novel
proteins with promising therapeutic potential, covered by
extensive and strong IP.
INSIGHT is seeking alliances and collaborations in the following
areas:
* Development of biogenerics for the ICH markets
* Distribution of finished biogenerics
* Development of small molecule anti-cancer and anti-inflammatory
drugs
* Development of recombinant Heparanase for bone marrow and stem
cell transplantation with improved efficiency.
